Quantification of myeloperoxidase from human granulocytes as an inflammation marker by enzyme.linked immunosorbent assay by Neumann, S. et al.
Quantitation of myeloperoxidase from human 
granulocytes as an inßammation marker 
by cnzyme-Iinkcd immunosorbent assay 
S. Neumann J. G. Gunzer I, H. Lang I, Mariannc J ochum 1, 
and H . Fritz ~ 
Biochemische Forschung E. Merek, Fra nHurter Straße 250, 
0 -6100 Oarmstadt 1, Federal Republic ofGennany 
2 Abteilung für Klinische Chemie und Klinische Biochemie, 
Chirurgische Klinik der Universität München, 
Nußbaumstraße 20, 0 -8000 Miinchen 2, 
Federal Republic of Germany 
Quantifizierung von Myeloperoxidase aus humanen Granulocyten 
als [ntlündungsparameter mittels J::nzymimmunoassay \'om 
SandwiehlYP 
Myeloperoxidase (donor: H20 2 oxidorcd uctase, EC 1.11.1.7) is 
a cationic heme enzyme of mol wt of approximately 140,000 
whieh is found as a main constituent of the azurophilic granules 
of polymorphonuclcar lcukoeytes (PMN) and in monocytcs 
(1]. Myclopcroxidase (MPO) plays an important role in killing 
bacteria using halide ions as a cofactor [2]. As a consequencc of 
phagocytosis MPO is discharged into phagolysosomes. Leakagc 
during phagocytosis or secretion on stimulation by various in-
flammatory mediators causes th.e appearance of extraccllular 
MPO activity. MPO activity outside of the cells may either 
stimulate inflammatory processes by oxidation ofphysiological 
substrates Jike IgG, C3b, Cl.1-proteinase inhibitor as weil as latent 
collagenase and by killing cells or may aLternatively modulate 
mflammatory activity by inactivation of cbemotactic peptides, 
lysosomal enzymes as weil as Fc- and C3b-rcceptors on 
phagocytes \3]. Quantita tive detennination of MPO in serum or 
plasma has been accomplished by radioimmunoassay [4] and in 
cell extracts or tissue extracts by enzyme assays. Here we 
describe a sandwicb-type enzyme-linked immunosorbent assay 
for quanti tation of MPO concentration iD plasma, broncho-
alveolar lavage fluid or extracts from granulocytes. 
Materials and mcthods 
MPQ was purified from nOnTIal human granulocytes by a proce-
durc involving acid elltraction of granules, copper chelate 
chromat0f::aphy, cation exchange chromatography on SP-
Sephadex M C-50 and size exclusion chromatography on 
Fractogelll.TId TSK HW·55 . Tbc final enzyme prepamtion was 
sho:wn to bc ffee of oth~r granular proteins by SOS-polyacryl-
amIde gel electrophores!s and immunoelectrophoresis against 
various polyvalent or monospecifi c autisera against granular 
components. - Antigen.spccific anlisera to MPO were raised 
in sheep and rabbilS. The IgG fractions were isolated by ammo-
nium sulfate precipitation and ion-exchange chromatography 
on O EAE cellulose. The specific IgG fractioD from rabbilS was 
isolatcd by adding immunoadsorption on MPO-agarose, and 
thcn coupled 10 calf intestinal alkaline pbosphatase with glutar-
dialdehyde as describcd previously {5]. 
For the enzyme immunoassay a procedure as reported pre-
~o~s!y fo r tbe compJell of PMN elastase Wilh Cl.1 -proteinase 
mh!bltor was followed analogously [6]. Brieny, polystyrcne 
tubcs (10.5 mm x 40 mm) werc coated by incubation wilh O.5 ml 
containing 50 ).lg sheep TgG 10 MPOJml in phosphate buffered 
saline pH 7.5 (PBS) at room temperature (20 to 2rq ovem ight 
and washed with 0.05% (wJv) polyoxyethylene (20)-sorbitan 
monolaurate scveral times before use. FOT tbe assay 0.5 ml 
sampie or calibrator was incubated in the coated tubes for I h 
at 20 10 22°C. Tbe tubes were washed three times, and 0.5 ml 
enzyme labellcd anlibodies to MPO in saJine Tris/HCI buffer 
pH 8.0 was added . After incubation for 2 h at 20 to 22~ C and 
wa~h ing of the tubes 0.5 ml substrate soLution, i.c. 10 mmol/l 
4-nitrophenyl phosphate in I molfl diethanolamine/HCI buffer 
pH 9.8 witb 0.5 mmol MgCI2/1, was dclivered to each tube and 
incubated for 1 hat 20 to 2rc. 0.5 ml 2 mol/l NaOH wasaddcd 
witb vortexing. Absorbance was read at 405 nm . A40s was 
plotted against MPO concentration on a linear seale. As a 
routine citrated pLasma was used in a final dilution of one part 
plasma plus 20 or 50 parts of PBS containing 1 mg bovine serum 
albumin/mi and 20 mmol EOTA/I. Calibrators wcre used in tbe 
same diluent pLus 2"/" (viv) citrated normal sheep plasma_ 
Results and discussion 
A linear calibration curve was obtained for thc range of 0 to 
20llg MPO/I. Unknowns werc detcrmined by reference 10 the 
calibration curve as calculated by linear regression analysis. 
Detection limit, i.e. mean absorbance of tbe blank plus 
3 x standard deviation, was abOllI 0.25 ).Ig/l. Sensitivi ty cor-
rcsponded to LlA = 0.004 in the calibration curve and 
approached O. I ).1g MPOjl. Within-run imprecision (coefficient 
of variation fo r 15 parallel detenninations) was in the range of 
8.4 to 6.8% with plasma sampies in the range of 32 to 143 Ilg 
MPO/I, respectively. Between-run imprecision (CV for aseries 
of 9 independent tests) was from 5.2 10 12.2% for 3 different 
commercially obtainable control plasma specimen. The assay 
was shown to be specific for myeloperoxidase as lactoferrin as 
weil as otbcr granular proteins when added to the sampie did 
not interfere. However, plasma conccntrations higher than 5% 
(vIv) impaired recovery, possibly by matrix effect(s). As the 
assay showed high sensitivity and reasonable precision with 
control plasma specimen we went on to measure myclo-
peroxidase levels in normal and pathological sampies. In a group 
of 156 apparently healthy persons the MPO concentration in 
citrated plasma was 36 ± 1 t.5)lg MPO/l (mean ± SO). In 
another group of 25 nonnal persons simila rly a range of 20 to 
60 IlgJI was fouo d. 
Patients sufTering from multiple trauma were studied 
longitudinally wilh 6 h intervals, measuring in citrated plasma 
MPO as weil as the complex of PMN clastase with Cl.1 -proteinase 
inhibitor whicb was previously shown to reOect tbe severity of 
the disease as weIL as complication by infections P}. Plasma 
levels of MPO sbowed a perfcct correlation with tbc PMN 
elastase complex levels with regard to rise aod fall, they were, 
however, lowcr in terms of concentration. Quite differently, in 
palients with adult respiratory dis tress syndrome (ARDS) in the 
analyses of bronehoalveolar lavage flu id high levels of MPO 
were observed which werc equal to or in severe eases even 
higher than theconcentration of tbe PMN elastasecomplex. 11 is 
argucd that the availabili ty of activc Cll -proleinase inhibitor for 
inactivation of PMN elaslase may bc Iimited here locally, and 
high. levels of MPO may botb signal the acuilY of the disease 
process and indicate the oxidative potential at the site of in-
nammation. 
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